Company intelligence / Profile preview

AbOrygen

Grasse, Provence-Alpes-Côte d'Azur, France

Ownership: Private
Development stage: Other

Overview

AbOrygen is a French bioinformatics company specializing in the development of innovative molecular biology software for life science research. Founded in 2004 and headquartered in Grasse, the company's flagship product is biOpen, a comprehensive sequence analysis platform designed to streamline genomic and proteomic workflows. biOpen integrates various tools for sequence alignment, vector cleaning, and project management, offering an intuitive interface and powerful visualization capabilities for researchers. AbOrygen's technology is used by academic and commercial laboratories to manage and analyze complex biological data efficiently.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on AbOrygen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AbOrygen.

Explore the full profile